Five-year results of ICG-Guided Photodynamic Therapy combined with intravitreal Ranibizumab for juxtapapillary polypoidal choroidal vasculopathy with macular involvement

被引：0
|
作者：
Petropoulos, I. K. [1 ]
Matter, M. A. [1 ]
Desmangles, P. M. [1 ]
机构：
[1] Ophthalmol Ctr Rive, Geneva, Switzerland
来源：
ACTA OPHTHALMOLOGICA | 2014年 / 92卷
关键词：
D O I：
10.1111/j.1755-3768.2014.F070.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
F070
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Five-Year Results of Combined Treatment for Polypoidal Choroidal Vasculopathy: Verteporfin PDT and Intravitreal Anti-VEGF
    Kwak, Hyung-Woo
    Yang, Ji Ho
    Bin Han, Jung
    Yu, Seung-Young
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [32] Combined Photodynamic Therapy With Verteporfin and Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
    Sato, Taku
    Kishi, Shoji
    Matsumoto, Hidetaka
    Mukai, Ryo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (06) : 947 - 954
  • [33] Efficacy of Intravitreal Bevacizumab Combined With Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    Gomi, Fumi
    Sawa, Miki
    Wakabayashi, Taku
    Sasamoto, Yuzuru
    Suzuki, Mihoko
    Tsujikawa, Motokazu
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (01) : 48 - 54
  • [34] Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
    Liu, Siyin
    Chhabra, Ramandeep
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (11) : 3533 - 3542
  • [35] Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
    Siyin Liu
    Ramandeep Chhabra
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 3533 - 3542
  • [36] Visual outcomes of polypoidal choroidal vasculopathy treated with intravitreal ranibizumab with or without photodynamic therapy
    Tan, Colin S.
    Ngo, Wei Kiong
    Lim, Louis W.
    ACTA OPHTHALMOLOGICA, 2018, 96 (02) : e254 - e255
  • [37] Reply to 'Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab'
    Ho, M.
    Lo, E. C.
    Young, A. L.
    Liu, D. T. L.
    EYE, 2015, 29 (09) : 1239 - 1239
  • [38] Reply to ‘Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab’
    M Ho
    E C Lo
    A L Young
    D T L Liu
    Eye, 2015, 29 : 1239 - 1239
  • [39] Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
    Weng, Hsin-Yu
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Ho, Wei-Ting
    Hsu, Yung-Ray
    Chen, Fang-Ting
    Chen, Yun-Ju
    Wang, Jia-Kang
    APPLIED SCIENCES-BASEL, 2021, 11 (03): : 1 - 9
  • [40] Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy
    Nishide, Tadayuki
    Hayakawa, Natsuki
    Nakanishi, Misako
    Ishii, Mai
    Okazaki, Shinya
    Kimura, Ikuko
    Shibuya, Etsuko
    Mizuki, Nobuhisa
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (10) : 2415 - 2420
12345